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Antimicrobial substances have long been sought in normal tissues and fluids 
in attempts to elucidate mechanisms of natural immunity. Many investigators 
have extracted such  materials from leucocytes during  the last 65  years but 
little has been done to clarify the relationship of these substances to disease 
resistance.  The lack  of knowledge concerning the  nature  of the  complex in 
vivo environment and the problems attendant to the isolation and purification 
of factors in tissue extracts have retarded progress. 
Hankin  (14),  in  1891, first observed that leucocyte extracts exhibited an  anti- 
bacterial action against  the anthrax bacillus.  Since this initial report, many other 
investigators have extracted antimicrobial  products from leucocytes.  Some of these 
reports dealt with heat-labile  fractions which were similar to serum alexin and most 
active against  Gram-negative bacteria  (10, 11,  13,  14). However, the majority of 
the leucocyte extracts possessing antimicrobial activity are more closely allied with 
the beta lysins of serum (4, 10, 12, 21, 24, 25, 26, 35, 38, 47). These latter substances, 
termed "leuk~ns"  by Schneider  (39), are relatively heat-stable,  requiring  tempera- 
tures of 65-80  ° for inactivation, and  they are more active against  Gram-positive 
bacteria. The chemical nature of these factors has not been defined other than to 
note that the antimicrobial  activity of some resides in the globulin  fraction of the 
leucocytes. 
In  much of the  early literature dealing  with  extractions of these factors from 
leucocytes,  the usual methods involved suspension  of the cells in physiologic saline 
and then allowing the liberation of cellular components by freeze-thawing or heating 
to about 50  ° for one-half  hour.  More recently, acid extractions (4,  12)  and sonic 
vibrations (8, 18) have been employed for this purpose. 
It has been well established that neutrophils are attracted in large numbers 
to local sites of irritation and  are  seen  to undergo  rapid  dissolution as  the 
inflammatory reaction develops. The pH in such a local area gradually changes 
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from alkaline to acid due to the accumulation of lactic acid which results from 
the  altered  metabolic  activities  of  the  leucocytes.  This  knowledge  offered  a 
rationale for the method employed here in the preparation  of aft antibacterial 
substance  from  neutrophilic  leucocytes.  It  was  thought  that  by  allowing 
leucocytes to undergo in vitro autolysis  in  a  simulated  inflammatory environ- 
ment,  the  possibility  of  obtaining  a  natural  antibacterial  substance  rather 
than  an  artifact  would  be enhanced.  By  the  use  of such  a  method,  a  potent 
antibacterial  factor was  obtained  and  its chemical composition determined. 
Materials a~d Methods 
Preparation of the Leucocyte Factor.-- 
Normal rabbits received 400 to 750 ml. of physiologic saline by intraperitoneal injection. 
An automatic media-dispensing apparatus  was used to pump the solution into immobilized 
rabbits. Th  9 peritoneal exudates of 20 to 25 rabbits were pooled for each extraction procedure. 
The leucocyte suspensions  were collected 12  to 14 hours later by drainage through rubber 
tubing attached  to a  large bore needle. The peritoneal suspensions,  consisting of 90 to 95 
per cent neutrophils, were drained into 250  ml. plastic centrifuge bottles and immediately 
centrifuged at 200 gravity for 5 to 10 minutes. The volume of the pooled leucocyte suspensions 
was usually between 2500 and 3000 ml. The centrifugate was resnspended in physiologic saline 
and any fibrin clots were filtered off onto loose gauze. After one additional saline wash the 
leucocytes were resuspended in saline, distilled water, buffers or 0.02  to 0.5 per cent lactic 
acid in saline. Care was taken to maintain a  temperature of 37 ° from the time of removal 
of the leucocytes from the rabbits until the extraction period was initiated. 
Extraction of the leucocytes in the various fluids was carried out in Erlenmeyer flasks for 
periods of 12 to 96 hours at 37  °. The pH of the extraction mixtures generally reached 2.5 to 
3.0 within 24 hours in the unbuffered systems. In the buffered systems 0.5 to 1.0 ~ phosphate 
buffer at pH levels of 8.0,  7.0,  and 6.0 were employed. Acetate buffer at 0.5 ~  concentra- 
tion was employed at pH levels of 5.0 and 4.0. In some cases the extraction flasks were placed 
on  a  shaking  apparatus  during  the incubation  period  to facilitate cellular disintegration. 
After extraction, cellular debris was centrifuged down at  1800 gravity for 45 minutes. The 
opalescent supernatant  was brought  to pH 7.0 with 2 N NaOH and the precipitate which 
formed was centrifuged at 1800 gravity for 30 minutes and discarded. The clear supematant 
was dialyzed in the cold for 30 hours against three changes of distilled water. The resulting 
precipitate was centrifuged for 30 minutes at  1800 gravity and discarded. The supernatant 
solution was brought to pH 4.5 with u  HC1 and allowed to stand in the cold for 12 hours. 
The precipitate which developed was centrifuged at  1800 gravity for 30 minutes and  dis- 
carded.  The supernatant  was lyophilized and weighed. The yield at this point was about 
500 to 700 mg. of dry product. A solution of this material at a concentration of 0.2 per cent 
in distilled water was brought to pH 6.5 with N NaOH and half saturated with ammonium 
sulfate. After standing at room temperature for 4 hours the precipitate was centrifuged at 
1800 gravity for 30 minutes and the supernatant discarded. The precipitate was resuspended 
in distilled water to the previous volume and dialyzed against distilled water until a negative 
Nessler test was  obtained  in the diffusate.  The material  in the cellophane bag was  then 
lyophilized and weighed, the yield being 200 to 400  rag.  This represented the final product 
which was tested  biologically and  studied chemically. An outline of the steps involved in 
this procedure is given in Fig. 1. 
As a  means for further purification a  stepwise ammonium sulfate fractionation was per- 
formed on aliquots of preparations prior to the usual ammonium sulfate precipitation step. R.  C. SKARNES AND  D. W.  WATSON  831 
An isoelectric point precipitation procedure (16) was employed in another attempt to improve 
the purity of the leucocyte factor. 
Characterization of the Leucocyt~ Fozmr.--To  test the antibacterial  activity 
of  the  factor  a  stock  pathogenic  strain  of  Micrococcus pyogenes var.  aureus 
was used. It was desired, in testing potency, to standardize activity on a weight 
basis. The unit activity of the factor was arbitrarily chosen as the least amount, 
in 10 ml. of growth medium, which prevented for 8 hours the outgrowth of an 
inoculum of 15 minion cells from a 12 hour broth culture. 
One and one-half strength nutrient broth (pH 8.2) was buffered with 1 nil. of 0.1 x, phos- 
phate at pH 8.2. The test systems and controis were incubated at 37 ° in screw-capped vials to 
which various amounts of the factor were added. Evidence of growth or growth inhibition was 
Saline-washed and centrifuged leucocytes 
I 
Suspended in saline, buffers, or dilute lactic acid and extracted for 60 to 72 hrs., 37 ° 
Centrifuged supernatant neutralized 
Precipitate discarded ~~~Supernatant  ~,dialyzed 
Precipitate discarded 4'''-  to pH 4.5  ~Supernatant  J~ 
Precipitate discarded 'c'-  Supernatant lyophilized 
50 per cent Saturation (NH,hSO4 
Supernatant discarded  Precipitate active fraction 
FIo. 1. General method for preparation of the leucocyte factor 
determined by direct turbidity measurements in a  Coleman Junior spectrophotometer at a 
wave length of 580 m~. 
In order to investigate the nature of the antihacterial property of the  leucocyte factor 
a standard inoculum of 15 milliun cells of the stock strain of M. aureus was added to tubes 
containing 15 hal. of buffered nutrient broth. Twenty #g. of the factor were added to half the 
tubes, the other tubes served as growth controls. The tubes were incubated at 37  ° and tripli- 
cate plate counts made from 0.5 ml. aliquots of each tube at 0, 2, 4, 6, 10, and 16 hours. 
Blockage of leucocyte factor antibacterial activity was examined when the acidic polymers 
desoxyribonucleic acid,  ribonucleic acid,  glutamyl polypeptide, and hyaluronic acid were 
added to the test systems just prior to inoculation with the stock strain. Turbidity readings 
were performed every 2 hours through a 10 hour period, during which time the ability of any 
particular acidic macromolecule to  reverse  growth  inhibition could be observed. Normal 
growth and growth inhibition controls were included with each experiment. 
The thermostability of the  leucocyte product was  examined in boiling distilled water 
at pH 5.0,  7.0, and 9.5.  The optimum pH for antihacterial activity was determined using 832  CHARACTERIZATION OF  LEUKIN 
phosphate buffer in the pH range from 6.0 to 8.S. The electrophoretic mobility of the material 
was measured in the portable  apparatus of the American Instrument Co., Silver Spring, 
Maryland.  The antibacterial selectivity of the product  was tested  against  various Gram- 
positive and negative  species. An enriched medium, Todd-Hewitt  broth,  was used when 
testing against the more fastidious microorganisms. 
Crystalline trypsin at a concentration of 0.1 per cent was added to 2 ml. volumes of 0.I 
per cent solutions of the leucocyte factor.  The pH was adjusted  to 7.8 and the mixtures 
incubated at room temperature for 12 hours or at 37  ° for 4 hours. The action of ribonuclease 
upon the biologic activity of the substance was also studied. The experimental conditions 
under which the enzyme acted have been described by Lancefield (23). The enzyme-treated 
extracts  were then examined for alteration of antibacterial  potency. The effect of MgSO4 
upon the antibacterial  power of the leucocyte factor was also investigated, using salt con- 
centrations of 50 and I00 pg. per ml. Ultraviolet absorption patterns were determined with 
the Beckman spectrophotometer, model DU, employing 0.05 per cent solutions of the factor. 
An amino acid analysis was performed following the method of Stein and Moore (31, 32). 
The dowex 50-X4 resin (-400 mesh) was used in the  column. The leucocyte product  was 
weighed from the lyophilized state in an amount of 6.25 rag. The product was hydrolyzed 
in a vacuum-sealed glass tube with 3.5 ml. of constant boiling hydrochloric acid for 48 hours 
at  II0  °. The hydrolysate  was washed carefully from the tube into a  round  bottom flask 
and vacuum distilled with three additions of distilled water. After the third distillation the 
residue was brought down to approximately a l ml. volume and carefully washed into a 25 
ml. volumetric flask with citrate  buffer, pH 3.1, and brought  to volume with buffer and 
distilled water.  The final pH of the diluted sample was 2.2. The sample was then filtered 
through a fiber glass filter pad and stored in the referigrator until used. 
Identification  of the  various'amino acid peaks was accomplished by comparison with 
previously obtained results with known amino acids whose relative positions had been dis- 
cerned by paper chromatographic methods (3). The total nucleic acid content of the leuco- 
cyte factor was determined from the phosphorus value (9), after three extractions in equal 
parts of ether and alcohol. Desoxyribonucleic acid was measured by a modification of the 
Dische test (40). The ribonucleic acid value was arrived at by subtraction of the Dische test 
result from the total nucleic acid value. Total carbohydrate was measured by the anthrone 
test (33) after deproteinization with trichloroacetic acid, and was based on glucose equiva- 
lents. The total protein content was determined from the amino acid assay and by the micro- 
Kjeldahl method (20). 
EXPERIMENTAL RESULTS 
Preparation of the Le~ocyte Factor.--Extraction of leucocytes in the various 
solutions yielded antibacterial fractions differing both in quantity and quality. 
When leucocytes were extracted in solutions buffered at pH 8.0,  7.0, and 6.0 
for  periods  of  12  to  24 hours,  small amounts of  two  different antibacterial 
factors  were  obtained.  One factor  rapidly lost  its  antibacterial power  upon 
standing in solution at 3 °. The pH for greatest activity of this factor was 6.0 
to 6.5. The other antibacterial factor which was stable and obtained in better 
yields in unbuffered or dilute lactic acid solutions was  the one chosen to  be 
investigated. 
Although it could be obtained from neutrophils by extraction in any of the 
different  solutions during various  time  intervals,  best  yields resulted when 
complete  cellular disintegration was  accomplished.  Greatest yields were  ob- R. C. SKARNES AND  D. W. WATSON  833 
tained when the leucocytes were extracted at 37 ° in dilute lactic acid (0.02 to 
0.5 per cent) in saline for 60 to 72 hours on a shaking apparatus. 
Attempts to concentrate the activity further by three different means proved 
unsatisfactory.  The  step-wise  ammonium  sulfate  procedure  yielded  three 
fractions which, when tested biologically, were less active than the whole half- 
saturated  product.  By recombining  the  three fractions the potency was  re- 
turned to that of the best preparations. Thus, the separation of the 50 per cent 
ammonium sulfate precipitate into three fractions had the  effect of diluting 
rather  than  concentrating  antibacterial  power.  The  isoelectric  point  pre- 
cipitation procedure gave three to four fractions which contained some activity 
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FIG. 2. The unit activity of one preparation of the leucocyte factor. 
but none of which appeared to concentrate the property. Electrophoretic runs 
were performed in an attempt to separate fast-moving boundaries. However, 
because of the  limited  water  solubility of the  leucocyte factor the patterns 
were difficult to follow. Several small,  rapidly diffusing boundaries were seen 
to migrate toward the negative pole at pH 7.0 but not in suf~cient quantity to 
warrant recovery efforts. 
Characterization  of the Leucocyte  Factor.--Fig.  2 illustrates the unit activity 
of one preparation of the material.  In this case, 3 ~g. per ml. prevented for 
8 hours the outgrowth of the  stock strain of M.  aureus.  The unit activities 
of these various leucocyte preparations varied between 2 and 5 #g. per ml. 
In testing the nature of the antibacterial property, it was found that  the 834  CHARACTERIZATION  OF  LEUKIN 
factor exhibited a  bactericidal effect upon M.  aureus.  Table  I  contains the 
results of this finding. Within 2 to 4 hours over 99 per cent of the initial popula- 
tion was killed. The eventual outgrowth which always occurred in the presence 
of low concentrations may have been the result of the existence of resistant 
forms in the population. The possibility also exists that the effective concen- 
tration of leucocyte factor was reduced as a  result of binding to  dead cells. 
If bacteria were exposed to relatively high concentrations of the factor,  (25 
to 50/~g. per ml.), the cultures failed entirely to grow out. 
The material was found to be very heat-stable at acid or neutral pH  but 
unstable at the alkaline reaction. Boiling a 0.1 to 0.2 per cent solution of the 
factor for 90 minutes at pH 5.0 or 7.0 did not reduce its bactericidal power and 
only a  slight reduction in potency resulted after 2 hours of boiling.  Solutions 
remained clear during the heating periods.  Solutions adjusted to pH 9.5  be- 
came cloudy and precipitated out soon after boiling was begun. No antibac- 
TABLE I 
The Nature of tke A ntibacterial Property of the Leucocyte Factor 
Time  Growth controls  Leucocyte factor 
ht'$, 
o 
2 
4 
6 
10 
16 
Av. No. bacteria 
1.5× 10  ~ 
9.5X  l0  s 
5.3 ×  107 
TNC 
TNC 
TNC 
Av. No. bacteria 
1.5 X  10  6 
1.1  X  10  ~ 
1.0×  104 
3.6× 104 
1.1 X 10  ~ 
TNC 
terial activity could be detected in solutions heated for 15  to 30 minutes at 
boiling temperature even when high concentrations of up to 100/~g. per ml. 
were tested. 
The  acidic polymers glutamyl polypeptide,  hyaluronic acid,  and  desoxy- 
ribonucleic acid effectively reversed the bactericidal action of the leucocyte 
product.  Ribonucleic acid was much less  effective and only large  ratios  of 
acid to leucocyte factor caused partial interference. Fig. 3 shows the blockage 
of antibacterial action by glutamyl polypeptide when the latter was added 
in a ratio 10:1. 
The optimum pH for greatest antibacterial action was found to be 8.2 as 
seen in Fig. 4. At pH levels of 8.5 and above, the growth controls did not grow 
out normally. Although the pH optimum was 8.2,  the factor was only slightly 
less active at pH values of 7.2 and 6.5. 
The product was tested against several species of bacteria with the results 
listed in Table II. All Gram-positive species were inhibited, while none of the 
Gram-negative  species  were  affected adversely at  the  concentration of  30 R. C. SKARNES  AND D. W. WATSON  835 
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FIG. 3. The interference by glutamyl polypeptide with the bactericidal property of the 
leucocyte factor against the staphylococcus.  The ratio of acid to factor is 10:1. 
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FIO. 4. The optimum pH for bactericidal action of the leucocyte factor. 
#g. per ml. Only concentrations higher than 100 #g. per ml. proved inimical 
to the Gram-negative bacteria tested. 
The  complex  growth  medium  required  by  certain  of  the  Gram-positive 
bacteria reduced somewhat the effectiveness of the leucocyte factor. Whereas 836  CHARACTERIZATION  OF  LEUKIN 
M. aureus could be effectively inhibited by 2 to 3 ~g. per ml. in nutrient broth, 
inhibition occurred only at concentrations of approximately 10 vg. per ml. in 
Todd-Hewitt broth. It is interesting to note that the type II pneumococcus, 
either in  the  rough or smooth phase  was very susceptible  to  the  leucocyte 
product. Microscopic examination of the exposed pneumococcal cells showed 
that the large majority were lysed within 4 hours. 
Exposure of the leucocyte factor to trypsin for a period of 12 hours at room 
temperature  or for 4  hours  at  37  °  abolished  the  bactericidal activity.  The 
enzyme ribonuclease did  not  alter antibacterial  action.  Neither enzyme ex- 
hibited an antibacterial property of its own at the concentrations utilized. 
TABLE II 
Range of Antibacterial Selectivity of the Leucocyte Factor* 
Bacterial species  Growth effect 
Micrococcus aureus 
Type II pneumococcus 
Type 28 streptococcus 
Type 4 streptococcus 
Streptococcus faecalis 
Type 18 streptococcus 
Salmonella typhosa 
Escherichia  coli 
Vibrio comma 
Proteus ~ulgaris 
Shigella  paradysenteriae 
Inhibition 
c~ 
Partial inhibition 
No inhibition 
cc  ~ 
* 30/~g. per ml. 
MgSO4 did not interfere with bactericidal action at concentrations which had 
previously been shown to reverse the antibacterial properties of two thymus 
peptides (1,  17).  Two ultraviolet absorption peaks were demonstrated. Fig. 5 
shows two curves, the lower curve represents the untreated leucocyte product. 
The peak  at  258  m/z reflects the presence of nucleic acid while the peak at 
275 m/~ represents protein material. The upper curve was obtained after the 
factor had been treated with ribonuclease. It can be observed that the protein 
peak has been shifted to the right to 278 m# suggesting a protein-nucleic acid 
association. 
Table  III  summarizes  the  characteristics  of  the  leucocyte factor  which 
have been  studied.  Prolonged dialysis led  to  a  gradual  loss  in  activity pre- 
sumably due  to  loss  through  the  dialyzing membrane.  When  a  solution  of 
the factor at a  concentration of 0.1  per cent was passed through Selas filter 
No. 0.02  no bactericidal activity was found in the filtrate probably because 
of adsorption to the filter. The factor had a limited water solubility, the maxi- AO0 
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FIG. 5. Ultraviolet absorption patterns of the leucocyte factor (0.05 per cent) before and 
after treatment with ribonuclease. 
TABLE HI 
Characterization of the Leucocyte Factor 
Property  Effect 
1  Dialyzability  1. 
2.  Filterability  2. 
3.  Heat stability  3. 
4.  Solubility  4. 
5.  Inhibition  of  activity  by  acidic  5. 
polymers 
6.  Optimum pH of action  6. 
7.  Electrophoretic  mobility  of  one  7. 
boundary 
8.  Antibacterial potency  8. 
9.  Antibacterial selectivity  9. 
10.  Action of enzymes 
11.  Action of MgSO4 
12.  UV absorption 
Slowly dialyzable 
Not passed by Selas filter 
Slight inactivation after boiling 2 hrs.  at acid 
or  neutral  pH.  Inactivated  in  30  rain.  at 
pH 9.5 
Soluble in water to 0.4 per cent. 
DNA  and  glutamyl  peptide  block  action, 
hyaluronate to a lesser degree 
pH 8.0 to 8.2 
15.7  X  l0 s  cm.  2  volt  -1  sec. -1  toward  the 
negative pole, pH 7.0 
2-10  /zg./ml.,  depending  upon  the  nutrient 
medium 
Active against gram positive pathogens: Group 
A  streptococci,  staphylococci,  pneumo- 
coccus  II.  Not  active  against  Gram-nega- 
tives: E. toll,  V. comma, S. typhosa,  P. vul. 
garis, Sh. paradysenteriae 
I0.  Trypsin  destroys  activity;  ribonuclease  does 
not 
11.  MgSO,  does  not  interfere  with  bactericidal 
action at a concentration of 100 ~ag./ml. 
12.  Absorption peaks at 258 and  277  millimicrons 
at 0.05 per cent concentration 
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mum concentration being 0.3  to 0.4 per cent at neutral to acid pH. The elec- 
trophoretic mobility of one fast moving boundary was found  to  15.7  X  10  -s 
cm3 volt-asec.  -1 Cacodylate buffer was used at pH 7.0 and at an ionic strength 
of 0.08. The current applied was 10 milliamperes. 
Many of the characteristics listed in Table III suggest that the antibacterial 
factor  might  be  a  basic  protein  or  polypeptide.  Although  the  preparation 
obtained  was  not  homogeneous,  an  amino  acid  analysis  was  performed  to 
TABLE IV 
Amino Acid Analysis of the Leucocyte Factor 
I.  Column chromatographic analysis 
Amino acid  Amino acid  on total  Amino acid  per  100  gin.  weight basis  total protein 
Asparfic acid  ................................ 
Threonine .................................. 
Serine  ...................................... 
ProUne ..................................... 
Glutamic Acid .............................. 
Glycine  .................................... 
Alanine .................................... 
Valine ..................................... 
Methionkne ................................. 
Isoleucine  .................................. 
Leucine .................................... 
Tyroslne ................................... 
Phenylalanine  ............................... 
Lysine ..................................... 
Histidine  ................................... 
Arginine  .................................... 
Ammonia  ................................... 
5.40 
3.86 
3.90 
5.61 
7.83 
5.42 
4.19 
8.60 
0.85 
4.03 
7.04 
1.86 
4.36 
3.91 
3.57 
14.63 
2.13 
gw~. 
6.2 
4.4 
4.5 
6.4 
9.0 
6.2 
4.8 
9.9 
1.0 
4.6 
8.1 
2.1 
5.0 
4.5 
4.1 
16.8 
2.5 
Total ....................................  87.19  100.1 
discover whether  it  contained  disproportionate amounts  of  the  basic amino 
acids. Table IV presents the result of this assay, in which it is seen that the 
basic amino  acid arginine predominated,  representing  nearly  17  per  cent  of 
the total protein. The other two  basic amino acids, lysine and histidine, were 
not present in unusual quantities. 
Total Composition of the Leucocyte  Factor.--The total protein value for the 
product  as  determined  by  the  amino  acid  analysis was  approximately 87.2 
per cent. An average protein value determined by the micro-Kjeldahl method 
was  found  to  be  90.0  per cent.  The  presence  of nucleic acids may have  ac- 
counted for the slightly higher value obtained by the latter method. R.  C.  SKARNES  AND  D.  W.  WATSON  839 
Total nucleic acids determined from the phosphorus content 0.90 per cent 
represent 8.2 per cent of the leucocyte factor. From the Dische test, desoxy- 
ribonucleic acid  appeared  to be present in  a  concentration of  1.5  per  cent. 
The  ribonucleic  acid  content  as  calculated  by  subtraction  of  the  desoxy- 
ribonucleic acid value from the  total nucleic acids represented 6.7  per  cent 
of the total weight. 
Total carbohydrate was determined by the anthrone test and found to be 
4.0 per cent. The total constituents of the factor are enumerated in Table V. 
More than 99 per cent of the product was accounted for on a weight basis. 
TABLE V 
Total  Constituents of ~I~ Leueocyt~ Factor 
1.  Total protein: 
(a) By amino acid analysis----87.2 per cent 
(b)  By micro-Kjeldahl  method--90.0 per cent 
2.  Total nucleic acids: (from total P---8.2 per cent) 
(a) DNA by Dische method--l.5 per cent 
(b) RNA difference----6.7  per cent 
3.  Total carbohydrate: 
(a)  Glucose equivalents by Anthrone test--4.0 per cent 
4.  Total components of sample: 
(a)  Protein--  87.2 per cent 
(b)  Nucleic acids--  8.2 per cent 
(c)  Carbohydrate--  4.0 per cent 
99.4 per cent total recovery 
DISCUSSION 
Two  different  antibacterial  factors  were  obtained  in  preliminary  experi- 
ments when leucocytes were permitted to break down at 37  ° in buffered physio- 
logic saline during a  24 hour extraction period. One such substance was quite 
unstable  and  most  effective at  acid  reaction.  Examination  of  the  cellular 
debris  at  this  time showed that  no intact  cells were present although most 
cell nuclei were whole, indicating that this factor may have been present in 
the  cytoplasm.  This  material  was  probably  related  to  some  antibacterial 
substances reported in the early literature (10,  11,  13, 44) and to phagocytin 
(18, 19). 
The other antibacterial  substance studied here was very stable and most 
active at  pH  8.2.  If leucocytes were extracted without buffer,  the pH  was 
found to reach 3.0 or 2.5 within 24 hours, probably owing to the accumulation 840  CHARACTERIZATION  OF  LEUKIN 
of  lactic acid.  Under  these  ciro]mqtances greater  yields of  the  stable  sub- 
stance  were  obtained,  particularly when  the  neutrophils were  extracted for 
2 to 3 days. Because of the acid reaction which develops in inflammatory sites 
and because of the better yield of leucocyte factor in acid extracts, leucocytes 
were subsequently suspended in dilute lactic acid-physiologic saline solutions 
and extracted for 60 to 72 hours at 37 °  . No intact cell nuclei could be detected 
after this prolonged extraction, indicating that the antibacterial factor origi- 
nated in the nuclear fraction. 
The  lower  the  extraction  pH,  the  greater  was  the  yield of  antibacterial 
factor obtained. This may have been the result of a greater release of protein 
from nucleic acids in the acid environment. If cellular debris which had been 
extracted for 2 to 3 days at near neutral pH was then extracted in lactic acid 
at pH 2.5 to 3.0,  more of the antibacterial factor was obtained in the super- 
natant. On the other hand, the cellular debris of leucocytes which had been 
extracted  in lactic acid for 3  days did not  give up  any more  antibacterial 
material upon further acid extraction. 
Unfortunately the methods used to further purify the final leucocyte product 
failed to concentrate antibacterial activity. However, the preparation proved 
quite potent in low  concentrations suggesting that it probably  contained a 
significant amount of the desired product. The fact that the activity was de- 
creased  rather  than  increased  by  fractionation  procedures  indicated  that 
the substance may have been bound to impurities or composed of different 
sized molecules some of which were more active than others. 
Many of the characteristics of the leucocyte factor suggested that it was a 
basic protein or polypeptide. In several of these characteristics is  resembled 
lysozyme and the basic thymus peptide of Bloom et al. (4).  However, it differed 
from it in certain important respects. It was low in lysine and high in arginine 
which was opposite to the finding with the thymus peptide. Its antibacterial 
selectivity differed from the  thymus peptide in  that the  pneumococcus was 
not  susceptible  to  the  peptide  while  two  Gram-negative  species  were  sus- 
ceptible (42). MgSO4 interfered with thymus peptide activity (1) but not with 
the  leucocyte factor,  and  the ultraviolet absorption peaks for the  two  sub- 
stances were different (4). The electrophoretic mobility of the factor appeared 
to be greater than that of the tissue peptide (4).  Although lysozyme activity 
was  found in  crude  extracts  of  the  leucocytes, none  remained  in  the  final 
product because of the 50 to 60 hour dialyzing period which was employed. 
Many characteristics of the leucocyte factor are shared by protamines. The 
protamines  are  known  to  contain  large  amounts of arginine  and  they are 
acid and heat-stable  (22).  They are inhibited by large acidic polymers (45), 
more active against Gram-positive bacteria  (30, 34),  most active at pH  8.1 
(30) and inactivated by trypsin (22). It is on these bases that the antibacterial 
factor  was  tentatively identified as  a  protamine  or  protamine  derivative. 
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first shown by Miescher in 1869. He extracted a nuclein  from human pus cells 
and  separated  the protein  portion  which  he  characterized  and  later  named 
protamine (29). 
The method of leucocyte extraction which usually involved an incubation 
period of 3 days in a lactic acid environment at pH 2.5 to3.0 may have been 
conducive to the formation of protamine  split products, possibly because of 
the acid environment,  or by the action of tissue cathepsins (43) or acid pro- 
teases such as the one found in lymphatic tissue by Hess et al.  (15). Further- 
more,  the  inhomogeneity  of  the  electrophoretic  patterns  may  have  been 
partly the result of migration of different sized protamine derivatives. Finally, 
the in vitro antimicrobial power of the leucocyte factor was much greater than 
that  reported  for  intact  protamine  molecules  (30,  27,  45).  The  splitting  of 
the protamine  molecule might  expose more of the basic ammonium  groups, 
accounting for increased activity. A  situation  analogous to this  is suggested 
by the work of Bloom and coworkers with the basic thymus peptide believed 
to have originated from a histone (4, 45). 
The review article by Bartholomew and Mittwer (2) summarized the litera- 
ture which established that the cell surfaces of Gram-positive bacteria contain 
ribonucleic acid.  This feature could provide these forms with a  greater nega- 
tively  charged  surface  than  is  the  case  with  the  Gram-negative  bacteria. 
Thus,  the positively charged ammonium groups on the leucocyte factor may 
be afforded a  greater opportunity for electrostatic attraction  to the cell sur- 
face with a  consequent disruption of cell metabolism. This may account for 
the  selectivity of  action  of  the  leucocyte product  upon  the  Gram-positive 
species. 
The finding  that  acidic  polymers could block the antibacterial property is 
of interest.  The  significance  of this  result has been discussed  in  a  previous 
publication  (41)  in  which  it  was  postulated  that  acidic  bacterial  capsules 
may offer protection to invading microorganisms  by reducing the effectiveness 
of basic antibacterial factors. However, in most instances the natural defenses 
of the host enable it to overcome invading microorganisms.  One facet of this 
natural  defense system may involve the elaboration of sufficient  amounts of 
basic tissue substances to offset this advantage of the parasite. 
The  question  of  whether  phagocytes,  particularly  neutrophils,  offer  re- 
sistence  to  infectious agents  by virtue  of their  phagocytic activity alone  is 
unsettled.  Metchnikoff believed that  the primary function of phagocytes in 
defense was the  act  of  phagocytosis  (28).  Contemporary  qualified  support 
for this concept is afforded by Wood (46). 
In view of the numerous reports concerning  the antimicrobial action of the 
variously  extracted  neutrophilic  substances,  an  additional  defense  role  for 
these cells has been suggested. Ribbert (36),  Dubos (7), and Cromartie et al. 
(5, 6),  among others, have observed what appeared to be an extracellular or 
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after microbial  agents were introduced into animal tissues they were seen to 
be surrounded,  but not immediately phagocytized,  by numerous polymorpho- 
nuclear leucocytes  in various  stages  of  dissolution.  It  is  possible  that  the 
degenerating  leucocytes  in  acidic  inflammatory sites  elaborate  substances 
inimical  to the invading organisms  thus rendering  them more susceptible  to 
ultimate destruction and  phagocytosis.  It  should  be  emphasized  that  this 
effect would most probably be localized; i.e.,  restricted to the immediate en- 
vironment of the leucocytes and microorganisms. The possibility that protamine 
derivatives might arise  within injured  neutrophils  is made more tenable by 
the findings of Rous (37) that certain areas within polymorphonuclear leuco- 
cytes exhibited a pH as low as 3.0. Thus, the opportunity for the elaboration 
of a leucocyte factor such as described above seems reasonable. 
The leucocyte  product which  has been  investigated in  this study is very 
likely similar  to  the  relatively heat-stable  substances  which  have  been  re- 
ported in the early literature. The greater heat stability of the substance  re- 
ported here may be a  consequence of the greater degree of purity obtained. 
Early work  on  the heat stability of many of the leucocyte  factors usually 
involved  heating periods  in whole or diluted serum.  It is probable  that the 
product described here would be less heat-stable if heated in the presence of 
serum. Such a basic substance  would be bound rapidly by serum proteins and 
its activity decreased. That this would be the case is indicated by the finding 
that a  complex medium like Todd-Hewitt broth reduces  the potency of the 
factor somewhat. 
Since the  relatively heat-stable  leucocyte  factors  reported  in  the  early 
literature  were  most  active  against  Gram-positive  bacteria  and  had  been 
named  "leukins" by Schneider  (39)  it  seems  superfluous  to  suggest  a  new 
term for the related leucocyte factor studied here. 
Several  investigators  have described  less heat-stable leucocyte substances 
which  were  most  active  against  Gram-negative  bacteria.  The  most  recent 
report is that of H~sch  (18, 19), who named the factor "phagocytJn."  This 
substance  was shown to be bactericidal  for many Gram-negative  species hut 
not for Gram-positive  pathogens.  Phagocytin was shown  to be  most active 
at acidic reactions but its chemical nature has not yet been ascertained. 
The  elaboration  by  polymorphonuclear  leucocytes  of  two  different anti- 
bacterial  factors may assume a significant role in the elucidation  of a natural 
defense mechanism  against both Gram-positive  and Gram-negative  bacteria. 
The leukin(s) may act against Gram-positive  species while the phagocytin(s) 
may attack Gram-negative forms. 
SUMMARy 
A method has been described for the preparation of a potent antibacterial 
factor from rabbit polymorphonuclear  leucocytes. Upon  characterization,  the R.  C.  SKARNES  AND  D.  W.  WATSON  843 
factor was found to possess many properties in common with basic proteins. 
The amino acid analysis revealed that it contained a  relatively large amount 
of arginine (17 per cent) and small amounts of the other two basic amino acids. 
It has therefore been identified as a protamlne or protamine derivative. 
The leucocyte factor was very active against all Gram-positive pathogens 
tested but exhibited little or no action against Gram-negative species. A possible 
explanation of this phenomenon has been discussed. The factor was very heat- 
stable at acid and neutral pH and its staphylococcidal activity was blocked 
by glutamyl polypeptide, hyaluronic acid, and desoxyribonucleic acid. 
Because  of  the  apparent  similarity of  the  product  studied here  to  other 
poorly defined leucocyte factors which had been termed leukins in the early 
literature, it is suggested that the name leukin be retained for it. The possible 
significance of this leukin in natural immunity has been discussed. 
The assistance of Mrs. Lina Taskovich in the amino acid analysis is gratefully acknowl- 
edged. 
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